SCHEMBL2199249

SCHEMBL2199249

Cc1cc(OCCO)ccc1C(=O)c1ccc(Nc2ccc(Br)cc2NC(=O)NCCO)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 9/20 0.49
MAPK12 P53778 9/20 0.49
MAPK11 Q15759 9/20 0.49
MAPK14 Q16539 9/20 0.49
PPARG P37231 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KDR P35968 2/20 0.37
FLT1 P17948 1/20 0.37
FLT4 P35916 1/20 0.37
LMNA P02545 2/20 0.36
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
HTT P42858 1/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2196296 0.93 MAPK13 (0.58) MAPK13MAPK12MAPK11MAPK14PPARG
SCHEMBL2199402 0.87 MAPK14 (0.55) MAPK13MAPK12MAPK11MAPK14PPARG
SCHEMBL2197456 0.86 MAPK13 (0.41) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL6821134 0.85 MAPK13 (0.61) MAPK13MAPK12MAPK11MAPK14PPARG
SCHEMBL2201202 0.84 MAPK14 (0.68) MAPK13MAPK12MAPK11MAPK14PPARG
SCHEMBL2198732 0.83 MAPK13 (0.73) MAPK13MAPK12MAPK11MAPK14PPARG
SCHEMBL2199317 0.82 MAPK13 (0.56) MAPK13MAPK12MAPK11MAPK14ALDH1A1
SCHEMBL2198438 0.81 MAPK13 (0.54) MAPK13MAPK12MAPK11MAPK14PPARG
SCHEMBL2200638 0.80 MAPK14 (0.67) MAPK13MAPK12MAPK11MAPK14PPARG
SCHEMBL6826625 0.79 MAPK13 (0.66) MAPK13MAPK12MAPK11MAPK14LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2006528597-A 2006-12-21 JP claimed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US claimed
EP-1658263-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS Leo Pharma A/S (DK) 2006-05-24 EP claimed
WO-2005009940-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA A/S (DK) 2005-02-03 WO claimed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed
EP-1658263-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS Leo Pharma A/S (DK) 2006-05-24 EP disclosed
WO-2005009940-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA A/S (DK) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK13 1063/4885MAPK12 955/4885MAPK11 612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.